Press Releases
Catalent Gene Therapy Facility Receives FDA Approval as an Additional Manufacturing Site for AveXis Gene Therapy
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it was approved by the U.S. FDA to produce commercial drug substance intermediate...
Press Releases
Alpha Capital LLC and OncoGenerix Announce New Pharmaceutical Factory in the US
Novel and generics pharma producer OncoGenerix and Alpha Capital LLC have come to an agreement to build a new injectable pharmaceutical factory in the US. The production facility will serve as an affiliate factory, similar to the one that...
Press Releases
U.S. Govt. Selects Grand River Aseptic Manufacturing to Help Combat COVID-19
Grand River Aseptic Manufacturing, a leading parenteral contract development and manufacturing organization (CDMO), has been selected by the U.S. Department of Health and Human Services and the U.S. Department of Defense to support the expansion of the United States’...
Press Releases
AGC Biologics, Novavax Expand Coronavirus Vax Pact
AGC Biologics, a global biopharmaceutical CDMO, announced it has expanded its partnership with Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases. AGC Biologics is currently preparing to manufacture Matrix-M™, the adjuvant component of Novavax’...
Press Releases
Moderna Announces Supply Agreement with U.S. Government for Initial 100 Million Doses of mRNA Vaccine Against COVID-19
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that the U.S. government has secured 100 million doses of mRNA-1273 as part of the U.S....
Press Releases
Glenmark introduces higher strength (400 mg) of FabiFlu to reduce pill burden of COVID-19 treatment
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced that it will introduce a 400 mg version of oral antiviral FabiFlu®, for the treatment of mild to moderate COVID-19 in India. The higher strength will improve patient compliance and...
Press Releases
Cherwell launches new support hub for growing Redipor prepared media distributor network
Cherwell Laboratories, specialist suppliers of environmental monitoring and process validation solutions for the pharmaceutical and related industries, has launched a Redipor® prepared media distributor resource centre website. Developing this new online knowledge hub supports Cherwell’s growing international distribution network...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read